Tyra Biosciences, Inc. (TYRA) DCF Valuation

Tyra Biosciences, Inc. (TYRA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Tyra Biosciences, Inc. (TYRA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (TYRA) DCF Calculator! With up-to-date Tyra Biosciences data and customizable assumptions, this tool empowers you to forecast, evaluate, and value Tyra Biosciences like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -3.1 -9.3 -26.1 -58.6 -79.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .1 .3 .4 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -3.1 -9.3 -26.3 -58.9 -79.9 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .1 15.2 302.2 251.2 203.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .3 .7 .6 1.1 4.7 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.3 -.7 -.6 -.8 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -3.1 -9.3 -26.1 -55.1 -79.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.8 -9.2 -26.7 -54.8 -76.8 -4.7 .0 .0 .0 .0
WACC, % 9.48 9.48 9.48 9.48 9.48 9.48 9.48 9.48 9.48 9.48
PV UFCF
SUM PV UFCF -4.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt -52
Equity Value 47
Diluted Shares Outstanding, MM 43
Equity Value Per Share 1.11

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Tyra Biosciences, Inc.'s (TYRA) financial data pre-filled to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life TYRA Financials: Pre-filled historical and projected data for Tyra Biosciences, Inc. (TYRA).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Tyra’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Tyra’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the comprehensive Excel file featuring Tyra Biosciences, Inc. (TYRA) financial data.
  • Customize: Tailor your projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and compare results instantly.
  • Make Decisions: Leverage the valuation outputs to inform your investment strategy.

Why Choose This Calculator for Tyra Biosciences, Inc. (TYRA)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your financial analysis.
  • Real-Time Adjustments: Instantly observe changes in Tyra’s valuation as you modify inputs.
  • Pre-Loaded Data: Comes equipped with Tyra's latest financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making strategic decisions.

Who Should Use This Product?

  • Professional Investors: Create comprehensive and trustworthy valuation models for assessing portfolio performance in Tyra Biosciences, Inc. (TYRA).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients regarding Tyra Biosciences, Inc. (TYRA).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotechnology firms like Tyra Biosciences, Inc. (TYRA) are valued in the financial landscape.

What the Template Contains

  • Pre-Filled DCF Model: Tyra Biosciences, Inc.’s (TYRA) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Tyra Biosciences, Inc.’s (TYRA) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.